Free Trial

AIA Group Ltd Sells 4,730 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • AIA Group Ltd has decreased its stake in UnitedHealth Group by 19.7%, now holding 19,253 shares valued at approximately $10.08 million.
  • Numerous analysts have revised their target prices for UnitedHealth Group, with estimates ranging from $198 to $390, while the consensus rating remains "Hold".
  • UnitedHealth Group announced an increase in its quarterly dividend to $2.21, reflecting a yearly yield of 3.5% and a payout ratio of 38.30%.
  • Need Better Tools to Track UnitedHealth Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

AIA Group Ltd reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,253 shares of the healthcare conglomerate's stock after selling 4,730 shares during the quarter. AIA Group Ltd's holdings in UnitedHealth Group were worth $10,084,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its holdings in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG grew its position in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after buying an additional 9,872 shares during the period. Sagespring Wealth Partners LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $8,860,000. Finally, TCM Advisors LLC grew its position in UnitedHealth Group by 7.5% during the fourth quarter. TCM Advisors LLC now owns 1,433 shares of the healthcare conglomerate's stock valued at $725,000 after buying an additional 100 shares during the period. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on UNH. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Finally, TD Securities reissued a "hold" rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $366.52.

Get Our Latest Analysis on UNH

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last quarter. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 2.5%

UNH stock opened at $250.74 on Monday. The company has a market capitalization of $227.46 billion, a PE ratio of 10.86, a price-to-earnings-growth ratio of 1.62 and a beta of 0.43. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company's 50 day moving average price is $291.78 and its two-hundred day moving average price is $405.18. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company's revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines